Anton Scharl

2.7k total citations
127 papers, 1.5k citations indexed

About

Anton Scharl is a scholar working on Oncology, Cancer Research and Obstetrics and Gynecology. According to data from OpenAlex, Anton Scharl has authored 127 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 33 papers in Cancer Research and 24 papers in Obstetrics and Gynecology. Recurrent topics in Anton Scharl's work include Breast Cancer Treatment Studies (30 papers), HER2/EGFR in Cancer Research (19 papers) and Ovarian cancer diagnosis and treatment (15 papers). Anton Scharl is often cited by papers focused on Breast Cancer Treatment Studies (30 papers), HER2/EGFR in Cancer Research (19 papers) and Ovarian cancer diagnosis and treatment (15 papers). Anton Scharl collaborates with scholars based in Germany, United States and Estonia. Anton Scharl's co-authors include G. Crombach, Nadia Harbeck, Christoph Thomssen, A. Bolte, Volkmar Müller, Klemens Scheidhauer, U. Pietrzyk, Thomas Papathemelis, H. Würz and H Schicha and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and American Journal of Obstetrics and Gynecology.

In The Last Decade

Anton Scharl

119 papers receiving 1.4k citations

Peers

Countries citing papers authored by Anton Scharl

Since Specialization

Citations

This map shows the geographic impact of Anton Scharl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anton Scharl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anton Scharl more than expected).

Fields of papers citing papers by Anton Scharl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anton Scharl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anton Scharl. The network helps show where Anton Scharl may publish in the future.

Co-authorship network of co-authors of Anton Scharl

This figure shows the co-authorship network connecting the top 25 collaborators of Anton Scharl. A scholar is included among the top collaborators of Anton Scharl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anton Scharl. Anton Scharl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Die Behandlung in zertifizierten Brustkrebszentren verbessert die Überlebenschancen von Patientinnen mit Brustkrebs 2024 ·Senologie - Zeitschrift für Mammadiagnostik und -therapie* ·Olaf Schoffer, Pauline Wimberger, Michael Gerken, (unknown), Christoph Bobeth, M Rößler, Patrik Dröge, (unknown), Christian Günster, (unknown), Theresa Link, Anton Scharl, Elisabeth C. Inwald, Karin Kast, Thomas Papathemelis, Olaf Ortmann, Monika Klinkhammer‐Schalke, Jochen Schmitt	1
2	Treatment in Certified Breast Cancer Centers Improves Chances of Survival of Patients with Breast Cancer 2024 ·Geburtshilfe und Frauenheilkunde ·Olaf Schoffer, Pauline Wimberger, Michael Gerken, (unknown), Christoph Bobeth, M Rößler, Patrik Dröge, (unknown), Christian Günster, (unknown), Theresa Link, Anton Scharl, Elisabeth C. Inwald, Karin Kast, Thomas Papathemelis, Olaf Ortmann, Monika Klinkhammer‐Schalke, Jochen Schmitt	6
3	Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM® fluorescence camera: a comparison between primary sentinel lymph node biopsy versus sentinel lymph node biopsy after neoadjuvant chemotherapy 2020 ·Journal of Cancer Research and Clinical Oncology ·(unknown), Anton Scharl, Atanas Ignatov, Olaf Ortmann, Elisabeth C. Inwald, Thomas Hildebrandt, Michael Gerken, Monika Klinkhammer‐Schalke, Sophia Scharl, Thomas Papathemelis	9
4	Shifting cancer care towards Multidisciplinarity: the cancer center certification program of the German cancer society 2017 ·BMC Cancer ·Christoph Kowalski, Ullrich Graeven, Christof von Kalle, Hauke Lang, Matthias W. Beckmann, Jens‐Uwe Blohmer, Martin Burchardt, Michael Ehrenfeld, Jan Fichtner, Stephan Grabbe, Hans Hoffmann, Heinrich Iro, Stefan Post, Anton Scharl, Uwe Schlegel, Thomas Seufferlein, Walter Stummer, D. Ukena, Julia Ferencz, Simone Wesselmann	62
5	Minimally Invasive Breast Fibroadenoma Excision Using an Ultrasound-Guided Vacuum-Assisted Biopsy Device 2017 ·Geburtshilfe und Frauenheilkunde ·Thomas Papathemelis, (unknown), Michael P. Lux, (unknown), Anton Scharl, Sophia Scharl	18
6	Significance of Ovarian Function Suppression in Endocrine Therapy for Breast Cancer in Pre-Menopausal Women 2016 ·Geburtshilfe und Frauenheilkunde ·Anton Scharl, (unknown)	3
7	The Right Treatment for the Right Patient – Personalised Treatment of Breast Cancer 2015 ·Geburtshilfe und Frauenheilkunde ·Anton Scharl, Thorsten Kühn, Thomas Papathemelis, (unknown)	16
8	Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective 2014 ·Breast Care ·Nadia Harbeck, Norbert Marschner, Michael Untch, Thomas Decker, Susanna Hegewisch‐Becker, Christian Jackisch, Jens Huober, Hans‐Joachim Lück, Gϋnter von Minckwitz, Anton Scharl, Andreas Schneeweiß, Hans Tesch, Anja Welt, Rachel Wuerstlein, Christoph Thomssen	7
9	Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physicians 2012 ·Breast Cancer Research and Treatment ·Falk C. Thiel, Michael Schrauder, Peter A. Fasching, Christian Löhberg, Mayada R. Bani, Lothar Häberle, (unknown), (unknown), Anton Scharl, Ingo Bauerfeind, (unknown), (unknown), (unknown), Matthias W. Beckmann, Michael P. Lux	15
10	Is first-line single-agent mitoxantrone in the treatment ofhigh-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial 2002 ·Annals of Oncology ·E. Heidemann, Herbert Stoeger, Rainer Souchon, (unknown), H. Bodenstein, C. Oberhoff, Jörg Fischer, Markus Schulze, Michael Clemens, Reinhard Andreesen, (unknown), Marton König, Anton Scharl, (unknown), M. Kaufmann	36
11	Immunohistochemical Detection of H-ras Protooncoprotein p21 Indicates Favorable Prognosis in Node-Negative Breast Cancer Patients 1999 ·Tumor Biology ·(unknown), (unknown), (unknown), Martina Becker, Christian M. Kurbacher, Anton Scharl	19
12	Amplification of the mdr1-gene is uncommon in recurrent ovarian carcinomas 1999 ·Cancer Letters ·Thomas Schöndorf, Anton Scharl, Christian M. Kurbacher, (unknown), Martina Becker, Rainer Neumann, (unknown), (unknown), Peter Mallmann, Uwe-Jochen Göhring	12
13	gastric cancer during early pregnancy two case reports 1996 ·Archives of Gynecology and Obstetrics ·Anton Scharl, Uwe-Jochen Göhring, P. Huber, Johann Lorenzen	15
14	Presurgical visualization of primary breast carcinoma with PET emission and transmission imaging. 1995 ·PubMed ·U. Pietrzyk, Klemens Scheidhauer, Anton Scharl, Alexander K. Schuster, H Schicha	18
15	Immunhistochemischer Nachweis des pS 2-Proteins an Paraffinschnitten von Mammakarzinomgeweben Vergleich mit den Ergebnissen eines immunoradiometrischen Assays 1995 ·Der Pathologe ·A. Ahr, Anton Scharl, (unknown), G. Crombach, (unknown)	3
16	A prospective study concerning psychological characteristics of patients with breast cancer 1994 ·Archives of Gynecology and Obstetrics ·(unknown), (unknown), U.-J. Göhring, Anton Scharl	11
17	Die Expression des p185^neu-Onkoproteins markiert eine ungünstige Prognose bei kleinen, nodal-negativen, nicht adjuvant systemisch behandelten Mammakarzinomen (T₁N₀) 1993 ·Geburtshilfe und Frauenheilkunde ·Uwe-Jochen Göhring, (unknown), Anton Scharl	5
18	Zytotoxizität von 16alpha-[<sup>125</sup>I]Jod-17beta-Östradiol für Ostrogenrezeptor-positive Mammakarzinomzellen <i>in vitro</i> 1991 ·Oncology Research and Treatment ·Anton Scharl, MW Beckmann, James R. Schreiber, John A. Holt	2
19	Rapid liver metabolism, urinary and biliary excretion, and enterohepatic circulation of 16alpha-radioiodo-17beta-estradiol 1991 ·International Journal of Radiation OncologyBiologyPhysics ·Anton Scharl, Matthias W. Beckmann, James E. Artwohl, Stig Kullander, John A. Holt	11
20	Explosiv wachsendes Zervixkarzinom mit ungewöhnlicher Metastasierung 1988 ·Geburtshilfe und Frauenheilkunde ·Anton Scharl	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact